 MMR vaccine contains protection against mumps | |
| Vaccine description | |
|---|---|
| Target | Mumps |
| Vaccine type | Attenuated |
| Clinical data | |
| MedlinePlus | a601176 |
| ATC code | |
| Identifiers | |
| ChemSpider |
|
| UNII | |
  (what is this?) (verify) | |
Mumps vaccines are vaccines which prevent mumps.[1] When given to a majority of the population they decrease complications at the population level.[1] Effectiveness when 90% of a population is vaccinated is estimated at 85%.[2] Two doses are required for long term prevention.[1] The initial dose is recommended between 12 and 18 months of age.[1] The second dose is then typically given between two years and six years of age.[1] Usage after exposure in those not already immune may be useful.[3]
Side effects are generally mild.[1][3] It may cause mild pain and swelling at the site of injection and mild fever.[1] More significant side effects are rare.[1] Evidence is insufficient to link the vaccine to complications such as neurological effects.[3] The vaccine should not be given to people who are pregnant or have very poor immune system function.[1] Poor outcomes among children of mothers who received the vaccine during pregnancy, however, have not been documented.[1][3] Even though the vaccine is developed in chicken cells, it is generally safe to give to those with egg allergies.[3]
Most of the developed world and many countries in the developing world include it in their immunization programs often in combination with measles and rubella vaccine known as MMR.[1] A formulation with the previous three and the varicella (chickenpox) vaccine known as MMRV is also available.[3] As of 2005, 110 countries provided the vaccine as part of their immunization programs.[1] In areas where widespread vaccination is carried out it has resulted in a more than 90% decline in rates of disease.[1] Almost half a billion doses of one variety of the vaccine has been given.[1]
- ^ a b c d e f g h i j k l m n World Health Organization (February 2007). "Mumps virus vaccines". Relevé Épidémiologique Hebdomadaire. 82 (7): 51–60. hdl:10665/240868. PMID 17304707.
- ^ Hviid A, Rubin S, Mühlemann K (March 2008). "Mumps". Lancet. 371 (9616): 932–944. doi:10.1016/S0140-6736(08)60419-5. PMID 18342688. S2CID 208793825.
- ^ a b c d e f Atkinson W (May 2012). Mumps Epidemiology and Prevention of Vaccine-Preventable Diseases (12 ed.). Public Health Foundation. pp. Chapter 14. ISBN 9780983263135. Archived from the original on 6 July 2016.